TrueBinding Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series E
  • (Cancelled)

  • Investors
  • 3

TrueBinding General Information

Description

Developer of a proprietary drug discovery platform designed to create novel monoclonal antibody therapeutics for complex and underserved conditions. The company offers an advanced antibody development platform targeting diseases such as Alzheimer's, Parkinson's, and Autism Spectrum Disorder, enabling patients with neurodegenerative and neurodevelopmental disorders to access innovative treatments that address neuroinflammation and protein aggregation.

Contact Information

Website
www.truebinding.com
Formerly Known As
Immutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4701 Patrick Henry Drive
  • Building 21
  • Santa Clara, CA 95054
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 4701 Patrick Henry Drive
  • Building 21
  • Santa Clara, CA 95054
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TrueBinding Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 02-Jan-2026 Cancelled Clinical Trials - Phase 2
5. Later Stage VC (Series D1) 20-Jun-2023 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series D) 03-Nov-2022 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series C) 16-Jun-2022 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 13-Jul-2020 $69.5M $72.5M Completed Clinical Trials - Phase 2
1. Seed Round 27-Oct-2017 $3M $3M Completed Pre-Clinical Trials
To view TrueBinding’s complete valuation and funding history, request access »

TrueBinding Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 30,000,000 $0.000010 $0.1 $0.1 1x $0.1 22.68%
To view TrueBinding’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TrueBinding Patents

  • 87

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 41

    Pending

  • Expiring in next 12 mo

TrueBinding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025264872-A1 Methods and compositions for treating neurodevelopmental disorders Pending 21-Jun-2024
US-20240352131-A1 Methods of treating eye disease Pending 18-Apr-2023
WO-2024220435-A1 Methods of treating eye disease Inactive 18-Apr-2023
US-20260250396-A1 Therapies with anti-gal3 antibodies Pending 28-Sep-2022
WO-2024073511-A2 Therapies with anti-gal3 antibodies Inactive 28-Sep-2022 G16H20/10
To view TrueBinding’s complete patent history, request access »

TrueBinding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TrueBinding Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wangsu Science & Technology Corporation Minority
ShangBay Capital Venture Capital Minority
Aethan Capital Venture Capital Minority
To view TrueBinding’s complete investors history, request access »

Ready to get started?

Request a free trial

TrueBinding FAQs

  • When was TrueBinding founded?

    TrueBinding was founded in 2016.

  • Where is TrueBinding headquartered?

    TrueBinding is headquartered in Santa Clara, CA.

  • What is the size of TrueBinding?

    TrueBinding has 30 total employees.

  • What industry is TrueBinding in?

    TrueBinding’s primary industry is Drug Discovery.

  • Is TrueBinding a private or public company?

    TrueBinding is a Private company.

  • What is TrueBinding’s current revenue?

    The current revenue for TrueBinding is .

  • How much funding has TrueBinding raised over time?

    TrueBinding has raised $250M.

  • Who are TrueBinding’s investors?

    Wangsu Science & Technology, ShangBay Capital, and Aethan Capital have invested in TrueBinding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process